Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 931, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2022.175219
Keywords
Hepatokines; Liver; Kidney; Diabetic nephropathy (DN); Liver-renal axis
Categories
Funding
- National Natural Science Foundation of China [81900069, 82000697]
Ask authors/readers for more resources
This review discusses the roles of hepatokines in diabetic nephropathy (DN) and their relationship with the liver-renal axis, proposing the potential therapeutic target of the liver-renal axis in DN.
Diabetic nephropathy (DN) is a serious complication of diabetes, and its pathogenesis has not been fully eluci-dated. Recently, communication between organs has gradually become a new focus in the study of diseases pathogenesis, and abnormal interorgan communication has been proven to be involved in the occurrence and progression of many diseases. As an important metabolic organ in the human body, the liver plays an important role in maintaining homeostasis in humans. The liver secretes a series of proteins called hepatokines that affect adjacent and distal organs through paracrine or endocrine signaling pathways. In this review, we summarize some of the hepatokines identified to date and describe their roles in DN to discuss the possibility that the liver -renal axis is potentially useful as a therapeutic target for DN. We summarize the important hepatokines identified thus far and discuss their relationship with DN. We propose for the first time that the liver-renal axis is a potential therapeutic target in individuals with DN.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available